Impact of Leaderboards on Training in a Gamified Dermoscopy App
Official title: Do Leaderboards Improve Self-regulated Training in a Gamified Dermoscopy Training App? A Randomized, Controlled Trial.
Run by Herlev Hospital · NCT06254547 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study tests if using leaderboards and motivational messages in a fun skin training app can help medical students learn better and stay engaged while diagnosing skin conditions.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Herlev Hospital Academic / other |
| Locations | 1 site (Herlev) |
| Trial ID | NCT06254547 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are medical students enrolled at Danish universities who have completed a university-level course on histology.
✕Probably not a fit
Patients who have prior experience with the Dermloop Learn app or equivalent dermatology training platforms may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates how leaderboards and daily motivational messages affect the learning and engagement of medical students using a gamified dermoscopy training app. Participants will be randomized into groups to receive different combinations of leaderboard visibility and motivational messages over a seven-day training period. The app features a library of over 10,000 skin lesions and provides instant feedback on diagnostic quizzes. The primary focus is on improving diagnostic accuracy and self-regulated learning through gamification techniques.
Why it matters
Potential benefit: If successful, this approach could enhance the training and diagnostic skills of medical students, leading to better identification of skin cancer.
How similar studies have gone: While gamification in medical education is gaining traction, this specific approach using leaderboards in dermoscopy training is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Medical student at a Danish university Exclusion Criteria: * Have not completed a university-level course on histology * Have completed or are currently enrolled in a clinical university course in dermatology * Prior experience with the app Dermloop Learn or equivalent experience via. courses or by using other training platforms for skin diagnosis.
Where it's running
-
Herlev Hospital
Herlev, Denmark Recruiting
Study contacts
- Study coordinator: Sigrid Kristensen, Bsc.med
- Email: sigrid.ip.kristensen@gmail.com
- Phone: +4542434557
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving sun protection for rural youth to prevent skin cancer
This study is testing a new way to help kids in rural areas of Utah and West Virginia protect themselves from the sun to prevent skin cancer.
-
High-intensity exercise and high-fiber diet for melanoma patients
This study is testing whether high-intensity exercise and a high-fiber diet can help improve health for melanoma patients receiving immunotherapy.
-
Mobile sun protection support to help young adults stay safe in the sun
This project tests a mobile health program to see if reminders, education, planning tools, and real-time sun exposure information can help young adults protect their skin from excessive sun exposure.
-
Psycho-physiological profiling of people with low versus high heat resilience
This project will test whether controlled heat and UV exposures plus physiological and psychological measurements can identify healthy adults who are more or less resilient to heat.
-
Cosibelimab for tough CSCC in kidney transplant recipients or blood cancers
This trial tests cosibelimab in people with advanced cutaneous squamous cell carcinoma who have a kidney transplant or certain blood cancers to see if it is safe and helpful for them.
-
First-line immunotherapy and PD-L1 testing for metastatic melanoma in Slovenia
This study will see if first-line immunotherapy (pembrolizumab, nivolumab, or ipilimumab plus nivolumab) works for adults in Slovenia with metastatic melanoma and whether PD-L1 measurements predict who responds.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.